• Tong Fang Lioe
  • R. Iain Cameron


This chapter outlines the anatomy, clinical presentation, and relevant clinical investigations. Details of both non-neoplastic and neoplastic pathological conditions affecting this organ site are given. Clinical considerations in obtaining the diagnostic biopsy and therapeutic resection specimens are outlined, with details of their handling and dissection in the histopathology laboratory. This is correlated with relevant histopathology reports, giving summary core prognostic and patient management items. Current WHO and TNM classifications are referenced.


Sentinel Node Sentinel Node Biopsy Needle Core Biopsy Fine Needle Aspiration Cytology Phyllode Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Allen DC, Cameron RI. Histopathology specimens: clinical, pathological and laboratory aspects. 1st ed. Berlin/Heidelberg: Springer; 2004.Google Scholar
  2. Dixon M. ABC of breast diseases. 2nd ed. London: BMJ books; 2000.Google Scholar
  3. Elston CW, Ellis IO, editors. The breast. Systemic pathology, vol. 13. 3rd ed. Edinburgh: Churchill Livingstone; 1998.Google Scholar
  4. Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening. Non-operative diagnosis subgroup of the National Coordinating Group for breast screening pathology. NHSBSP publication no 50; 2001.Google Scholar
  5. Institute of Biomedical Science/The Royal College of Pathologists. IBMS guidance to candidates and trainers for advanced specialist diploma in breast pathology dissection. Accessed at http://www.rcpath/org/index.asp?PageID=1664. Accessed on December 2011.
  6. Pathology reporting of breast disease: a joint document incorporating the third edition of the NHS Breast Screening Programme Guidelines for pathology reporting in breast cancer screening and the second edition of the Royal College of Pathologists Minimum dataset for breast cancer histopathology. NHSBSP publication No 58: 2005. Accessed at
  7. Pinder SE, Provanzano E, Earl H, Ellis IO. Laboratory handling and histology reporting of breast specimens from patients who have received neoadjuvant chemotherapy. Histopathology. 2007;50:409–17.PubMedCrossRefGoogle Scholar
  8. Provenzano E, Pinder SE. Guidelines for the handling of benign and malignant surgical breast specimens. Curr Diagn Pathol. 2007;13:96–105.CrossRefGoogle Scholar
  9. Purdie CA. Sentinel lymph node biopsy. Review of the literature and guidelines for pathological handling and reporting. Curr Diagn Pathol. 2007;13:106–15.CrossRefGoogle Scholar
  10. Rosen PP. Rosen’s breast pathology. 3rd ed. Philadelphia: Lippincott, Williams and Wilkins; 2009.Google Scholar
  11. Rosen PP, Obermann HA. Tumors of the mammary gland. Atlas of tumor pathology, 3rd series. Fascicle 7. Washington DC: AFIP: 1993.Google Scholar
  12. Sainsbury JRC, Anderson TJ, Morgan DAL. ABC of breast diseases. Breast cancer. BMJ. 2000;321:745–50.PubMedCrossRefGoogle Scholar
  13. Tavassoli F, Devilee P. WHO classification of tumors. Tumors of the breast and female genital organs. Lyon: IARC Press; 2003.Google Scholar
  14. The Royal College of Pathologists. Breast cancer dataset and tissue pathways. Accessed at
  15. Walker RA, Bartlett JMS, Dowsett M, Ellis IO, Hanby AM, Jasani B, Miller K, Pinder SE. Her2 testing in the UK: further update to recommendations. J Clin Pathol. 2008;61:318–24.CrossRefGoogle Scholar
  16. Wittekind C, Greene L, Hutter RVP, Klimfinger M, Sobin LH. TNM Atlas: illustrated guide to the TNM/pTNM classification of malignant tumors. 5th ed. Berlin/Heidelberg: Springer; 2005.Google Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  1. 1.Histopathology LaboratoryBelfast City Hospital, Belfast Health and Social Care TrustBelfastUK
  2. 2.Histopathology LaboratoryAltnagelvin Hospital, Western Health and Social Care TrustLondonderryUK

Personalised recommendations